ROYALTY PHARMA RAISES $600 MILLION OF DEBT

New York, NY – May 24, 2012 – Royalty Pharma, the industry leader in acquiring royalty interests in marketed and late stage biopharmaceutical products, announced that it has successfully issued $600 million of incremental Term Loan B debt through RPI Finance Trust (“RPIFT”), bringing total debt outstanding at RPIFT to approximately $3.4 billion. Proceeds will be used to fund future acquisitions.

Source: Original Article